Total debt rose to $2.6B in Q2 2026 from $2.0B a year earlier, lifting D/E to 1.17 from 0.64, while retained earnings swung to a -$750.8M deficit, reflecting a $1.2B loss in Q4 2025.
Acadia Healthcare Company, Inc. (ACHC) balance sheet — 15-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|
| Total Current Assets | 881.32M | 814.14M | 577.49M | 596M | 506.13M | 495.03M | 2.52B | 542.21M | 450.42M | 471.55M | 427.93M | 294.74M | 274.14M | 145.13M | 140.98M | 112.61M |
| Cash & Short-Term Investments | 163.31M | 133.24M | 76.31M | 100.07M | 97.65M | 133.81M | 378.7M | 99.53M | 50.51M | 67.29M | 57.06M | 11.21M | 94.04M | 4.57M | 49.4M | 61.12M |
| Cash Only | 163.31M | 133.24M | 76.31M | 100.07M | 97.65M | 133.81M | 378.7M | 99.53M | 50.51M | 67.29M | 57.06M | 11.21M | 94.04M | 4.57M | 49.4M | 61.12M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 501.38M | 545.16M | 421.98M | 429.53M | 353.74M | 304.45M | 297.08M | 321.06M | 318.09M | 344.97M | 314.77M | 239.43M | 134.59M | 106.12M | 63.87M | 35.13M |
| Days Sales Outstanding | 57.5 | 60.07 | 48.83 | 53.53 | 49.46 | 48.01 | 51.88 | 58.35 | 38.54 | 44.39 | 40.87 | 48.7 | 48.9 | 54.29 | 57.21 | 57.92 |
| Inventory | 6.25M | 5.69M | 5.65M | 5.3M | 5.09M | 4.79M | 4.85M | 4.08M | 5.05M | 4.79M | 4.63M | 4.68M | 20.16M | 15.7M | 11.38M | 6.24M |
| Days Inventory Outstanding | 0.77 | 0.76 | 0.85 | 0.86 | 18.53 | 19.26 | 20.3 | 1.25 | 1.04 | 1.06 | 1.02 | 1.62 | 11.79 | 12.86 | 16.03 | 13.56 |
| Other Current Assets | 159.27M | 83.04M | 32.2M | 25.01M | 10.6M | 17.69M | 1.81B | 90.19M | 45.96M | 75.23M | 75.45M | 40.4M | 46.73M | 38.27M | 27.71M | 16.36M |
| Total Non-Current Assets | 4.67B | 4.71B | 5.38B | 4.76B | 4.48B | 4.27B | 3.98B | 6.34B | 5.72B | 5.95B | 5.6B | 3.99B | 1.95B | 1.08B | 842.43M | 300.39M |
| Property, Plant & Equipment | 3.19B | 3.25B | 2.97B | 2.38B | 2.09B | 1.9B | 1.72B | 1.6B | 3.11B | 3.05B | 2.7B | 1.71B | 1.07B | 370.11M | 236.94M | 82.97M |
| Fixed Asset Turnover | 1.06x | 1.02x | 1.06x | 1.23x | 1.25x | 1.21x | 1.22x | 1.26x | 0.97x | 0.93x | 1.04x | 1.05x | 0.94x | 1.93x | 1.72x | 2.67x |
| Goodwill | 1.32B | 1.3B | 2.26B | 2.23B | 2.22B | 2.2B | 2.11B | 2.09B | 2.4B | 2.75B | 2.68B | 2.13B | 802.99M | 661.55M | 557.4M | 186.81M |
| Intangible Assets | 100.19M | 96.67M | 70M | 73.28M | 76.04M | 70.14M | 68.53M | 68.83M | 88.99M | 87.35M | 83.31M | 59.58M | 21.64M | 20.57M | 15.99M | 8.23M |
| Long-Term Investments | 46.6M | 21.6M | 8.8M | 0 | 0 | 0 | 0 | 0 | 60.52M | 13M | 73.51M | 18.3M | 0 | -15.7M | -11.38M | 0 |
| Other Non-Current Assets | 67.24M | 50.95M | 43.24M | 72.55M | 92.7M | 94.97M | 79.13M | 2.58B | 64.93M | 49.57M | 51.32M | 20.21M | 41.98M | 27.31M | 32.1M | 16.37M |
| Total Assets | 5.55B | 5.53B | 5.96B | 5.36B | 4.99B | 4.77B | 6.5B | 6.88B | 6.17B | 6.42B | 6.02B | 4.29B | 2.22B | 1.22B | 983.41M | 413M |
| Asset Turnover | 0.62x | 0.60x | 0.53x | 0.55x | 0.52x | 0.49x | 0.32x | 0.29x | 0.49x | 0.44x | 0.47x | 0.42x | 0.45x | 0.58x | 0.41x | 0.54x |
| Asset Growth % | -42.45% | -7.21% | 11.16% | 7.44% | 4.61% | -26.64% | -5.52% | 11.45% | -3.92% | 6.64% | 40.56% | 92.76% | 81.57% | 24.53% | 138.12% | - |
| Total Current Liabilities | 552.03M | 525.19M | 577.92M | 885.78M | 388.33M | 404.86M | 1.31B | 463.58M | 416.38M | 377.39M | 342.87M | 290.2M | 165.93M | 114.69M | 71.85M | 40.67M |
| Accounts Payable | 138.56M | 150.4M | 232.7M | 156.13M | 104.72M | 98.58M | 87.81M | 90.26M | 117.74M | 102.3M | 80.03M | 91.34M | 48.7M | 36.03M | 19.08M | 8.64M |
| Days Payables Outstanding | 18.06 | 20.11 | 34.78 | 25.37 | 381.48 | 396.68 | 367.4 | 27.62 | 24.16 | 22.62 | 17.61 | 31.62 | 28.49 | 29.51 | 26.88 | 18.78 |
| Short-Term Debt | 32.5M | 50.69M | 76.82M | 29.22M | 21.25M | 18.59M | 153.48M | 43.68M | 34.11M | 34.83M | 34.8M | 45.36M | 26.96M | 15.2M | 7.68M | 6.75M |
| Deferred Revenue (Current) | 9.22M | 2.81M | 1.69M | 2.17M | 6.65M | 30.37M | 35.95M | 1.9M | 32.15M | 31.34M | 28.8M | 146M | 2.07M | 0 | 0 | 0 |
| Other Current Liabilities | 174.84M | 132.66M | 808K | 512.74M | 0 | 0 | 744.61M | 148.69M | 111.89M | 108.86M | 93.63M | 64.99M | 3.15M | 23.93M | 16.34M | 9.08M |
| Current Ratio | 1.60x | 1.55x | 1.00x | 0.67x | 1.30x | 1.22x | 1.93x | 1.17x | 1.08x | 1.25x | 1.25x | 1.02x | 1.65x | 1.27x | 1.96x | 2.77x |
| Quick Ratio | 1.59x | 1.54x | 0.99x | 0.67x | 1.29x | 1.21x | 1.93x | 1.16x | 1.07x | 1.24x | 1.23x | 1.00x | 1.53x | 1.13x | 1.80x | 2.62x |
| Cash Conversion Cycle | 40.21 | 40.71 | 14.9 | 29.02 | -313.48 | -329.41 | -295.22 | 31.98 | 15.42 | 22.83 | 24.29 | 18.7 | 32.2 | 37.64 | 46.37 | 52.69 |
| Total Non-Current Liabilities | 2.75B | 2.86B | 2.19B | 1.59B | 1.7B | 1.78B | 3.29B | 3.91B | 3.42B | 3.47B | 3.51B | 2.31B | 1.18B | 629.26M | 479.01M | 275.96M |
| Long-Term Debt | 2.32B | 2.47B | 1.88B | 1.34B | 1.36B | 1.48B | 2.97B | 3.11B | 3.16B | 3.21B | 3.25B | 2.2B | 1.07B | 601.94M | 465.64M | 270.71M |
| Capital Lease Obligations | 512.44M | 132.68M | 101.83M | 111.7M | 116.43M | 116.84M | 84.03M | 85.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 324.29M | 66.61M | 83.95M | 1.93M | 92.59M | 74.37M | 50.02M | 22.82M | 80.37M | 80.33M | 78.52M | 23.94M | 63.88M | 7.97M | 998K | 6.01M |
| Other Non-Current Liabilities | 207.15M | 190.89M | 122.3M | 129.22M | 125.03M | 110.5M | 188.73M | 696.3M | 154.27M | 166.43M | 164.86M | 86.66M | 43.51M | 19.35M | 12.38M | 5.25M |
| Total Liabilities | 3.3B | 3.39B | 2.77B | 2.47B | 2.09B | 2.19B | 4.6B | 4.37B | 3.84B | 3.85B | 3.86B | 2.6B | 1.34B | 743.95M | 550.86M | 316.63M |
| Total Debt | 2.5B | 2.65B | 2.09B | 1.51B | 1.53B | 1.64B | 3.26B | 3.26B | 3.19B | 3.24B | 3.29B | 2.24B | 1.1B | 617.14M | 473.32M | 277.46M |
| Net Debt | 2.34B | 2.52B | 2.01B | 1.41B | 1.43B | 1.5B | 2.88B | 3.16B | 3.14B | 3.17B | 3.23B | 2.23B | 1B | 612.57M | 423.92M | 216.34M |
| Debt / Equity | 1.11x | 1.24x | 0.65x | 0.52x | 0.53x | 0.63x | 1.71x | 1.30x | 1.35x | 1.25x | 1.50x | 1.32x | 1.24x | 1.28x | 1.09x | 2.88x |
| Debt / EBITDA | 4.68x | 4.60x | 3.10x | 2.36x | 2.61x | 3.14x | 7.45x | 4.35x | 5.59x | 5.58x | 5.67x | 5.83x | 5.34x | 4.41x | 6.01x | - |
| Net Debt / EBITDA | 4.37x | 4.37x | 2.99x | 2.21x | 2.45x | 2.89x | 6.59x | 4.21x | 5.50x | 5.46x | 5.57x | 5.80x | 4.88x | 4.37x | 5.39x | - |
| Interest Coverage | -5.69x | -6.68x | 3.94x | 0.69x | 6.36x | 4.58x | 2.16x | 1.68x | 1.36x | 2.49x | 2.45x | 3.01x | 3.58x | 3.30x | 2.10x | -3.19x |
| Total Equity | 2.25B | 2.14B | 3.19B | 2.89B | 2.9B | 2.58B | 1.9B | 2.51B | 2.36B | 2.6B | 2.19B | 1.7B | 880.97M | 480.71M | 432.55M | 96.36M |
| Equity Growth % | -128.14% | -32.92% | 10.5% | -0.46% | 12.32% | 35.98% | -24.18% | 6.07% | -8.98% | 18.75% | 28.7% | 92.75% | 83.26% | 11.13% | 348.87% | - |
| Book Value per Share | 24.55 | 23.60 | 34.66 | 31.75 | 31.69 | 28.45 | 21.44 | 28.53 | 27.06 | 29.81 | 25.42 | 24.83 | 15.92 | 9.56 | 11.18 | 5.14 |
| Total Shareholders' Equity | 2.02B | 1.95B | 3.07B | 2.78B | 2.81B | 2.52B | 1.9B | 2.51B | 2.33B | 2.57B | 2.17B | 1.69B | 880.97M | 480.71M | 432.55M | 96.36M |
| Common Stock | 909K | 905K | 918K | 913K | 899K | 890K | 880K | 877K | 874K | 871K | 867K | 707K | 592K | 501K | 499K | 321K |
| Retained Earnings | -716.32M | -765.84M | 387.33M | 131.72M | 153.39M | -119.75M | -310.39M | 361.75M | 252.82M | 428.57M | 220.14M | 220.99M | 101.44M | 18.4M | -24.18M | -44.58M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | -371.37M | -414.88M | -462.38M | -374.12M | -549.57M | -104.65M | -68.37M | -29.29M | -24.18M | -5.82M |
| Minority Interest | 229.88M | 191.59M | 117.12M | 105.69M | 88.26M | 65.39M | 0 | 0 | 28.81M | 22.42M | 17.75M | 8.05M | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying ACHC stock.
As of 2025, Acadia Healthcare Company, Inc. (ACHC) had total assets of $5.53B including $814.1M in current assets.
Acadia Healthcare Company, Inc. (ACHC) carries total debt of $2.65B, offset by $133.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Acadia Healthcare Company, Inc. (ACHC) has total shareholders' equity (book value) of $1.95B ($23.60 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Acadia Healthcare Company, Inc. (ACHC) reported a current ratio of 1.55x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Litigation and labor costs
Metrics are mathematically derived from official filings.
Balance Sheet Shrinks Amid Legal Overhang
Total assets contracted from $6.4B in Q3 2025 to $5.5B in Q2 2026, while equity halved to $2.0B, reflecting a $1.2B loss in Q4 2025, as per recent SEC filings.
The sharp decline in equity, from $3.1B to $2.0B, appears driven by a massive non-recurring charge in Q4 2025, likely related to legal settlements or impairments. This has weakened the balance sheet's capacity to absorb future shocks, though the current ratio improved to 1.57, suggesting adequate short-term liquidity. Investors should monitor whether further charges erode equity further.
Leverage Spikes as Debt Load Grows
Total debt rose to $2.6B in Q2 2026 from $2.0B a year earlier, lifting D/E to 1.17 from 0.64, indicating increased leverage, as reported in quarterly financial statements.
The D/E ratio nearly doubled year-over-year, but this is partly due to the equity base halving rather than a dramatic increase in absolute debt. The absolute debt increase of $600M suggests funding for operations or settlements, not growth, given CapEx cuts. With cash of only $171M, the company appears to rely on debt for liquidity, which may raise refinancing risk if credit conditions tighten.
Asset Mix Shifts to Heavier PPE
PPE net grew to $3.2B in Q2 2026 from $2.5B in Q2 2024, while goodwill fell from $2.3B to $1.3B, indicating a shift toward tangible assets, based on balance sheet data.
The $1.0B reduction in goodwill likely reflects an impairment charge, which is consistent with the Q4 2025 loss. Meanwhile, PPE expansion suggests continued investment in facilities, but the slowdown in CapEx to 4.5% of revenue in Q2 2026 implies this trend may not persist. The asset mix is becoming more tangible, which could improve collateral value but also signals a potential overcapacity if occupancy remains constrained by labor shortages.
Retained Earnings Deepen Deficit
Retained earnings swung from a positive $411.7M in Q3 2025 to a deficit of -$750.8M in Q2 2026, reflecting cumulative losses, as per recent balance sheet filings.
The swing of over $1.1B in retained earnings underscores the magnitude of the Q4 2025 charge, which appears to be a non-cash impairment or legal accrual. This has eroded the equity buffer, leaving the company with negative retained earnings. While no dividends or buybacks were paid, the lack of capital returns is prudent given the need to preserve cash, but the equity quality is now strained.
Liquidity Improves but Cash Buffer Thin
Current ratio rose to 1.57 in Q2 2026 from 1.18 in Q2 2024, yet cash of $171M covers only about 8% of total debt, as reported in financial statements.
The improvement in current ratio suggests better working capital management, but the absolute cash position remains modest relative to debt and operating needs. With operating cash flow of $162M in Q2 2026, the company can cover near-term obligations, but the thin cash buffer leaves little room for unexpected legal settlements or labor cost spikes. Investors should monitor whether cash generation remains sufficient to service debt.
Goodwill Impairment Masks Core Value
Goodwill dropped by $1.0B to $1.3B in Q2 2026, likely reflecting an impairment that distorts the balance sheet's true economic picture, as per recent 10-Q filings.
The impairment appears tied to the Q4 2025 loss, but it may not reflect a permanent decline in the underlying business value, given the JV moat and stable revenue. However, the remaining $1.3B goodwill still represents a significant intangible asset that could be at risk if operational performance deteriorates further. This distortion makes the reported equity understated, and investors should adjust for non-recurring charges when assessing the balance sheet's health.